# 4D Molecular Therapeutics (stock symbol: FDMT) Logo in transparent PNG and SVG formats

## 4D Molecular Therapeutics Logo large

### 4D Molecular Therapeutics Logo large Download PNG (33.62 KB)

![4D Molecular Therapeutics Logo large Download PNG (33.62 KB)](/img/orig/FDMT_BIG-ca8ee1e3.png)

### 4D Molecular Therapeutics Logo large Download SVG (2.01 KB)

![4D Molecular Therapeutics Logo large Download SVG (2.01 KB)](/img/orig/FDMT_BIG-30638f75.svg)

## 4D Molecular Therapeutics Logo icon format

### 4D Molecular Therapeutics Logo icon format Download PNG (63.31 KB)

![4D Molecular Therapeutics Logo icon format Download PNG (63.31 KB)](/img/orig/FDMT-832f85aa.png)

### 4D Molecular Therapeutics Logo icon format Download SVG (1.2 KB)

![4D Molecular Therapeutics Logo icon format Download SVG (1.2 KB)](/img/orig/FDMT-e630f511.svg)

## 4D Molecular Therapeutics Logo large for dark backgrounds

### 4D Molecular Therapeutics Logo large for dark backgrounds Download PNG (21.92 KB)

![4D Molecular Therapeutics Logo large for dark backgrounds Download PNG (21.92 KB)](/img/orig/FDMT_BIG.D-9ef22a54.png)

### 4D Molecular Therapeutics Logo large for dark backgrounds Download SVG (1.85 KB)

![4D Molecular Therapeutics Logo large for dark backgrounds Download SVG (1.85 KB)](/img/orig/FDMT_BIG.D-ca4116c8.svg)

## 4D Molecular Therapeutics Logo icon format for dark backgrounds

### 4D Molecular Therapeutics Logo icon format for dark backgrounds Download PNG (13.73 KB)

![4D Molecular Therapeutics Logo icon format for dark backgrounds Download PNG (13.73 KB)](/img/orig/FDMT.D-1fb452c8.png)

### 4D Molecular Therapeutics Logo icon format for dark backgrounds Download SVG (1.15 KB)

![4D Molecular Therapeutics Logo icon format for dark backgrounds Download SVG (1.15 KB)](/img/orig/FDMT.D-22d6f148.svg)

## About 4D Molecular Therapeutics

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1/2 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; CRF; Roche; and CFF. The company was founded in 2013 and is headquartered in Emeryville, California.4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical trials: 4D-125 that is in a Phase 1/2 clinical trial for the treatment of X-linked retinitis pigmentosa; 4D-110 that is in a Phase 1/2 clinical trial for the treatment of choroideremia; and 4D-310, which is in a Phase 1/2 clinical trial for the treatment of Fabry disease. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration and 4D-710 for the treatment of cystic fibrosis lung disease. 4D Molecular Therapeutics, Inc. has research and collaboration arrangements with uniQure; CRF; Roche; and CFF. The company was founded in 2013 and is headquartered in Emeryville, California.

1. Website domain: 4dmoleculartherapeutics.com
2. Employees: 138
3. Marketcap: $0.59 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
